US Patent 7491725 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors

Patent 7491725 was granted and assigned to Bristol-Myers Squibb on February, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7491725

Date of Patent

February 17, 2009

Patent Application Number

11192867

Date Filed

July 29, 2005

Patent Citations Received

‌

US Patent 12064428 Kinase inhibitor salts and compositions thereof

‌

US Patent 11833249 Rapidly disintegrating solid oral dosage forms containing dasatinib

‌

US Patent 11980619 Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and uses

‌

US Patent 12064430 Kinase inhibitor salts and compositions thereof

Patent Primary Examiner

‌

Kamal A Saeed

Patent abstract

The invention relates to processes for preparing compounds having the formula,

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7491725 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API